Cargando…

Evaluating α-galactosylceramide as an adjuvant for live attenuated influenza vaccines in pigs

Natural killer T (NKT) cells activated with the glycolipid ligand α-galactosylceramide (α-GalCer) stimulate a wide variety of immune cells that enhance vaccine-mediated immune responses. Several studies have used this approach to adjuvant inactivated and subunit influenza A virus (IAV) vaccines, inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Artiaga, Bianca L., Morozov, Igor, Ransburgh, Russell, Kwon, Taeyong, Balaraman, Velmurugan, Indran, Sabarish V., De Carvalho Madrid, Darling Melany, Gu, Weihong, Henningson, Jamie, Ma, Wenjun, Richt, Jürgen A., Driver, John P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339466/ https://www.ncbi.nlm.nih.gov/pubmed/35936354 http://dx.doi.org/10.1186/s44149-022-00051-x

Ejemplares similares

Comparison of oseltamivir and α-galactosylceramide for reducing disease and transmission in pigs infected with 2009 H1N1 pandemic influenza virus
por: Madrid, Darling Melany de C., et al.
Publicado: (2022)

Susceptibility of swine cells and domestic pigs to SARS-CoV-2
por: Meekins, David A., et al.
Publicado: (2020)

Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells
por: Driver, John P., et al.
Publicado: (2020)

α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant
por: Artiaga, Bianca L., et al.
Publicado: (2016)

SARS-CoV-2 infection, disease and transmission in domestic cats
por: Gaudreault, Natasha N., et al.
Publicado: (2020)

A single-cell analysis of thymopoiesis and thymic iNKT cell development in pigs
por: Gu, Weihong, et al.
Publicado: (2022)

Experimental Infection of Domestic Pigs with African Swine Fever Virus Isolated in 2019 in Mongolia
por: McDowell, Chester D., et al.
Publicado: (2022)

Experimental re-infected cats do not transmit SARS-CoV-2
por: Gaudreault, Natasha N., et al.
Publicado: (2021)

Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer
por: Cool, Konner, et al.
Publicado: (2021)

Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer
por: Cool, Konner, et al.
Publicado: (2021)

Susceptibility of White-Tailed Deer to Rift Valley Fever Virus
por: Wilson, William C., et al.
Publicado: (2018)

Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective
por: Yang, Guan, et al.
Publicado: (2017)

Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine
por: Gableh, Fateme, et al.
Publicado: (2016)

Susceptibility of sheep to experimental co-infection with the ancestral lineage of SARS-CoV-2 and its alpha variant
por: Gaudreault, Natasha N., et al.
Publicado: (2021)

Susceptibility of sheep to experimental co-infection with the ancestral lineage of SARS-CoV-2 and its alpha variant
por: Gaudreault, Natasha N., et al.
Publicado: (2022)

Comparison of Rift Valley fever virus replication in North American livestock and wildlife cell lines
por: Gaudreault, Natasha N., et al.
Publicado: (2015)

Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant
por: Singh, Shailbala, et al.
Publicado: (2014)

Identification of host factors for Rift Valley Fever Phlebovirus
por: Balaraman, Velmurugan, et al.
Publicado: (2023)

Identification of Host Factors for Rift Valley Fever Phlebovirus
por: Balaraman, Velmurugan, et al.
Publicado: (2023)

Rapid control of pandemic H1N1 influenza by targeting NKT-cells
por: Artiaga, Bianca L., et al.
Publicado: (2016)

Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression
por: Nakamura, Makoto, et al.
Publicado: (2021)

Novel approaches to develop Rift Valley fever vaccines
por: Indran, Sabarish V., et al.
Publicado: (2012)

The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines
por: Liu, Yonghui, et al.
Publicado: (2021)

Glucosylceramide and galactosylceramide, small glycosphingolipids with significant impact on health and disease
por: Reza, Safoura, et al.
Publicado: (2021)

The pig as a mixing vessel for influenza viruses: Human and veterinary implications
por: Ma, Wenjun, et al.
Publicado: (2008)

Intra-Peritoneal Hyperthermia Combining α-Galactosylceramide in the Treatment of Ovarian Cancer
por: Wu, Chao-Chih, et al.
Publicado: (2013)

Production of α-Galactosylceramide by a Prominent Member of the Human Gut Microbiota
por: Wieland Brown, Laura C., et al.
Publicado: (2013)

Repeated administration of alpha-galactosylceramide ameliorates experimental lupus nephritis in mice
por: Uchida, Takahiro, et al.
Publicado: (2018)

The PGRMC1 Antagonist AG-205 Inhibits Synthesis of Galactosylceramide and Sulfatide
por: Wang-Eckhardt, Lihua, et al.
Publicado: (2021)

Efficient synthesis of α-galactosylceramide and its C-6 modified analogs
por: Li, Huiting, et al.
Publicado: (2022)

Characterization of a Glycolipid Synthase Producing α-Galactosylceramide in Bacteroides fragilis
por: Caballé, Marc, et al.
Publicado: (2022)

Stability of SARS-CoV-2 in Biological Fluids of Animals
por: Kwon, Taeyong, et al.
Publicado: (2023)

An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses
por: Longet, Stephanie, et al.
Publicado: (2019)

Classical Swine Fever Outbreak after Modified Live LOM Strain Vaccination in Naive Pigs, South Korea
por: Je, Sang H., et al.
Publicado: (2018)

Assembly of Myelin by Association of Proteolipid Protein with Cholesterol- and Galactosylceramide-Rich Membrane Domains
por: Simons, Mikael, et al.
Publicado: (2000)

Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues
por: Janssens, Jonas, et al.
Publicado: (2017)

Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines
por: Davitt, Christopher J. H., et al.
Publicado: (2019)

Synthesis and Immunological Activity of Novel Oligo(ethylene glycol) Analogues of α-Galactosylceramide
por: Pawar, Mithun S., et al.
Publicado: (2022)

Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide
por: Croudace, Joanne E, et al.
Publicado: (2008)

Galactosylceramide Affects Tumorigenic and Metastatic Properties of Breast Cancer Cells as an Anti-Apoptotic Molecule
por: Owczarek, Tomasz B., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8trjemul57c1ssknmsnqmrqd5o